- Home
- KRUS vs PRTA Comparison
KRUS vs PRTA Comparison
Compare KRUS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- PRTA
- Stock Information
- Founded
- KRUS 2008
- PRTA 2012
- Country
- KRUS United States
- PRTA Ireland
- Employees
- KRUS N/A
- PRTA N/A
- Industry
- KRUS Restaurants
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- KRUS Consumer Discretionary
- PRTA Health Care
- Exchange
- KRUS Nasdaq
- PRTA Nasdaq
- Market Cap
- KRUS 911.2M
- PRTA 809.8M
- IPO Year
- KRUS 2019
- PRTA N/A
- Fundamental
- Price
- KRUS $76.98
- PRTA $5.80
- Analyst Decision
- KRUS Buy
- PRTA Buy
- Analyst Count
- KRUS 9
- PRTA 9
- Target Price
- KRUS $74.67
- PRTA $27.67
- AVG Volume (30 Days)
- KRUS 276.8K
- PRTA 2.4M
- Earning Date
- KRUS 07-08-2025
- PRTA 08-07-2025
- Dividend Yield
- KRUS N/A
- PRTA N/A
- EPS Growth
- KRUS N/A
- PRTA N/A
- EPS
- KRUS N/A
- PRTA N/A
- Revenue
- KRUS $258,444,000.00
- PRTA $137,935,000.00
- Revenue This Year
- KRUS $19.53
- PRTA N/A
- Revenue Next Year
- KRUS $18.60
- PRTA $30.93
- P/E Ratio
- KRUS N/A
- PRTA N/A
- Revenue Growth
- KRUS 21.37
- PRTA 54.55
- 52 Week Low
- KRUS $40.03
- PRTA $4.32
- 52 Week High
- KRUS $110.66
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- KRUS 59.89
- PRTA 46.16
- Support Level
- KRUS $75.72
- PRTA $4.95
- Resistance Level
- KRUS $83.69
- PRTA $6.00
- Average True Range (ATR)
- KRUS 4.37
- PRTA 0.32
- MACD
- KRUS -0.10
- PRTA 0.25
- Stochastic Oscillator
- KRUS 64.42
- PRTA 88.59
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).